Sustained formation of α-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-α, but not NADPH oxidase

Free Radical Biology and Medicine

Volumn 42, Issue 3, 2007, Pages 335-342

  Woods, Courtney G ^a   Burns, Amanda M ^a   Maki, Akira ^a   Bradford, Blair U ^a   Cunningham, Michael L ^b   Connor, Henry D ^c   Kadiiska, Maria B ^c   Mason, Ronald P ^c   Peters, Jeffrey M ^d   Rusyn, Ivan ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA(4 PYRIDYL 1 OXIDE) N TERT BUTYLNITRONE; FREE RADICAL; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR BIS(2 ETHYLHEXYL)PHTHALATE; PHTHALIC ACID; PIRINIXIC ACID; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE; CONTROLLED STUDY; DIET; ELECTRON SPIN RESONANCE; HYPOTHESIS; KUPFFER CELL; LIVER; LIVER CARCINOGENESIS; MALE; MOLECULAR BIOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SAMPLE; TREATMENT DURATION; WILD TYPE;

ANIMALS; DIETHYLHEXYL PHTHALATE; FREE RADICALS; KUPFFER CELLS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; PEROXISOME PROLIFERATORS; PPAR ALPHA; PYRIDINES; PYRIMIDINES; REACTIVE OXYGEN SPECIES;

RODENTIA;

EID: 33845925868     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.10.053     Document Type: Article

References (48)

1. Lake B.G. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis. Toxicol. Lett. 82-83 (1995) 673-681
2. Reddy J.K., Azarnoff D.L., and Hignite C.E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283 (1980) 397-398
3. Reddy J.K., and Rao M.S. Peroxisome proliferation and hepatocarcinogenesis. IARC Sci. Publ. (1992) 225-235
4. Cattley R.C., DeLuca J., Elcombe C., Fenner-Crisp P., Lake B.G., Marsman D.S., Pastoor T.A., Popp J.A., Robinson D.E., Schwetz B., Tugwood J., and Wahli W. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?. Regul. Toxicol. Pharmacol. 27 (1998) 47-60
5. Marsman D.S., Cattley R.C., Conway J.G., and Popp J.A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48 (1988) 6739-6744
6. Peters J.M., Cheung C., and Gonzalez F.J. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?. J. Mol. Med 83 (2005) 774-785
7. Rusyn I., Kadiiska M.B., Dikalova A., Kono H., Yin M., Tsuchiya K., Mason R.P., Peters J.M., Gonzalez F.J., Segal B.H., Holland S.M., and Thurman R.G. Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells. Mol. Pharmacol. 59 (2001) 744-750
8. Conway J.G., Tomaszewski K.E., Olson M.J., Cattley R.C., Marsman D.S., and Popp J.A. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis 10 (1989) 513-519
9. Suzuki Y.J., Forman H.J., and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med 22 (1997) 269-285
10. Yeldandi A.V., Rao M.S., and Reddy J.K. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448 (2000) 159-177
11. Rose M.L., Rivera C.A., Bradford B.U., Graves L.M., Cattley R.C., Schoonhoven R., Swenberg J.A., and Thurman R.G. Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Carcinogenesis 20 (1999) 27-33
12. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., and Gonzalez F.J. Targeted disruption of the alpha isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15 (1995) 3012-3022
13. Akiyama T.E., Nicol C.J., Fievet C., Staels B., Ward J.M., Auwerx J., Lee S.S., Gonzalez F.J., and Peters J.M. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J. Biol. Chem 276 (2001) 39088-39093
14. phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182 (1995) 751-758
15. Zhong Z., Froh M., Connor H.D., Li X., Conzelmann L.O., Mason R.P., Lemasters J.J., and Thurman R.G. Prevention of hepatic ischemia-reperfusion injury by green tea extract. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G957-G964
16. Tomaszewski K.E., Derks M.C., and Melnick R.L. Acyl CoA oxidase is the most suitable marker for hepatic peroxisomal changes caused by treatment of F344 rats with di(2-ethylhexyl)phthalate. Toxicol. Lett. 37 (1987) 203-212
17. Rose M.L., Germolec D., Arteel G.E., Schoonhoven R., and Thurman R.G. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Chem. Res. Toxicol. 10 (1997) 1198-1204
18. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55 (1953) 416-421
19. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150 (1985) 76-85
20. Dikalova A.E., Kadiiska M.B., and Mason R.P. An in vivo ESR spin-trapping study: free radical generation in rats from formate intoxication-role of the Fenton reaction. Proc. Natl. Acad. Sci. USA 98 (2001) 13549-13553
21. Hayashi Y., Ueda Y., Nakajima A., and Mitsuyama Y. EPR evidence of hydroxyl radical generation as an initiator of lipid peroxidation in amyloid beta-protein-stimulated PC12 cells. Brain Res. 1025 (2004) 29-34
22. Rusyn I., Denissenko M.F., Wong V.A., Butterworth B.E., Cunningham M.L., Upton P.B., Thurman R.G., and Swenberg J.A. Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. Carcinogenesis 21 (2000) 2141-2145
23. Reddy J.K., and Rao M.S. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res. 214 (1989) 63-68
24. Nemali M.R., Reddy M.K., Usuda N., Reddy P.G., Comeau L.D., Rao M.S., and Reddy J.K. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol. Appl. Pharmacol. 97 (1989) 72-87
25. Rusyn I., Rose M.L., Bojes H.K., and Thurman R.G. Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators. Antiox. Redox Signal. 2 (2000) 607-621
26. Nemali M.R., Usuda N., Reddy M.K., Oyasu K., Hashimoto T., Osumi T., Rao M.S., and Reddy J.K. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 48 (1988) 5316-5324
27. Reddy J.K., Goel S.K., Nemali M.R., Carrino J.J., Laffler T.G., Reddy M.K., Sperbeck S.J., Osumi T., Hashimoto T., and Lalwani N.D. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. USA 83 (1986) 1747-1751
28. Fan C.Y., Pan J., Usuda N., Yeldandi A.V., Rao M.S., and Reddy J.K. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J. Biol. Chem. 273 (1998) 15639-15645
29. Rusyn I., Peters J.M., and Cunningham M.L. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit. Rev. Toxicol. 36 (2006) 459-479
30. Rose M.L., Rusyn I., Bojes H.K., Belyea J., Cattley R.C., and Thurman R.G. Role of Kupffer cells and oxidants in signaling peroxisome proliferator- induced hepatocyte proliferation. Mutat. Res. 448 (2000) 179-192
31. Fridovich I. Biological effects of the superoxide radical. Arch. Biochem. Biophys. 247 (1986) 1-11
32. Dunford H.B. Free radicals in iron-containing systems. Free Radic. Biol. Med 3 (1987) 405-421
33. Towner R.A., Qian S.Y., Kadiiska M.B., and Mason R.P. In vivo identification of aflatoxin-induced free radicals in rat bile. Free Radic. Biol. Med 35 (2003) 1330-1340
34. Nichols P., and Schonbaum G.R. Catalases. In: Boyer P.D. (Ed). The enzymes (1963), Academic Press, New York 147-225
35. 2 production by peroxisomes. Eur. J. Biochem. 176 (1988) 477-484
36. 2 production in intact liver. Toxicol. Lett. 60 (1992) 61-68
37. Klucis E., Crane D.I., Hughes J.L., Poulos A., and Masters C.J. Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate. Biochim. Biophys. Acta 1074 (1991) 294-301
38. Oikawa I., and Novikoff P.M. Catalase-negative peroxisomes: transient appearance in rat hepatocytes during liver regeneration after partial hepatectomy. Am. J. Pathol. 146 (1995) 673-687
39. Milton M.N., Elcombe C.R., and Gibson G.G. On the mechanism of induction of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate. Biochem. Pharmacol. 40 (1990) 2727-2732
40. Powanda M.C., Blackburn B.S., Bostian K.A., Fowler J.P., Hauer E.C., and Pekarek R.S. Clofibrate-induced alterations in zinc, iron and copper metabolism. Biochem. Pharmacol. 27 (1978) 125-127
41. Huang H.L., and Shaw N.S. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet. Toxicol. Appl. Pharmacol. 180 (2002) 118-128
42. Fischer J.G., Glauert H.P., Yin T., Sweeney-Reeves M.L., Larmonier N., and Black M.C. Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect NF-kappaB activation induced by the peroxisome proliferator, Wy-14,643. J. Nutr. 132 (2002) 2525-2531
43. Hertz R., Seckbach M., Zakin M.M., and Bar-Tana J. Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem. 271 (1996) 218-224
44. Kono H., Rusyn I., Yin M., Gabele E., Yamashina S., Dikalova A., Kadiiska M.B., Connor H.D., Mason R.P., Segal B.H., Bradford B.U., Holland S.M., and Thurman R.G. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J. Clin. Invest. 106 (2000) 867-872
45. Sato K., Kadiiska M.B., Ghio A.J., Corbett J., Fann Y.C., Holland S.M., Thurman R.G., and Mason R.P. In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS. FASEB J. 16 (2002) 1713-1720
46. Rusyn I., Yamashina S., Segal B.H., Schoonhoven R., Holland S.M., Cattley R.C., Swenberg J.A., and Thurman R.G. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res. 60 (2000) 4798-4803
47. Peters J.M., Cattley R.C., and Gonzalez F.J. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18 (1997) 2029-2033
48. Rusyn I., Asakura S., Pachkowski B., Bradford B.U., Denissenko M.F., Peters J.M., Holland S.M., Reddy J.K., Cunningham M.L., and Swenberg J.A. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res. 64 (2004) 1050-1057